Tumour markers in the diagnosis of bronchial carcinoma: New options using fuzzy logic-based tumour marker profiles

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 10, 1998, Pages 565-574

  Keller, Thomas ^b   Bitterlich, Norman ^b   Hilfenhaus, Stefanie ^b   Bigl, Heidrun ^a   Löser, Thomas ^b   Leonhardt, Peter ^a  

^a Robert Koch Klinik   (Germany)

^b pe Diagnostik GmbH   (Germany)

Author keywords

Bronchogenic carcinoma; Fuzzy logic; Lung cancer; Non small cell carcinoma; Small cell carcinoma; Tumour markers

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; DIAGNOSTIC ACCURACY; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOMA; LUNG MODEL; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL;

EID: 0031763115     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050216     Document Type: Article

References (26)

1. Arroliga AC, Matthay RA (1993) The role of bronchoscopy in lung cancer. Lung Cancer 14:87-98
2. Bocklisch SF, Bitterlich N (1994) Fuzzy pattern classification methodology and application. In: Kruse R, Gebhardt J, Palm R (eds) Fuzzy systems in computer science. Vieweg, Wiesbaden
3. Ebert W, Muley T, Drings P (1996) Does the assessment of serummarkers in patients with lung cancer aid in the clinical decision making process? Anticancer Res 16:2161-2168
4. Ebert W, Hoppe M, Muley T, Drings P (1997) Monitoring of therapy in inoperable lung cancer patients by measurement of CYFRA 21-1, TPA-TP CEA, and NSE. Anticancer Res 17:2875-2878
5. Everone CA (ed) (1997) Lung Cancer base report: Available at URL http:/www.fis.org/lungc.html
6. Giovanella L, Piantanida R, Ceriani L, Bandera M, Novario R, Bianchi L, Roncari G (1997) Immunoassay of neuron-specific enolase (NSE) and serum fragments of cytokeratin 19 (CYFRA 21-1) as tumor markers in small cell lung carcinoma: clinical evaluation and biological hypothesis. Int J Biol Markers 12:22-26
7. Hemdon RC, Lancaster JL, Toga AW, Fox PT (1996) Quantification of white and gray matter volumes from T1 parametric images using fuzzy classifiers. J Magn Reson Imaging 6:425-435
8. Hermanek P, Sobin LH (eds) (1992) International Union Against Cancer (UICC) TNM classification of malignant tumours, 4th edn. (1987, revised 1992) Springer, Berlin Heidelberg New York
9. Huang MS, Jong SB, Tsai MS, Lin MS, Chong IW, Lin HC, Hwang JJ (1997) Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma. Respir Med 91:135-142
10. Kalmanson D, Stegall F (1975) Cardiovascular investigation and fuzzy concepts. Am J Cardiol 35:30-34
11. Margolis ML, Hyzy JB, Schenken LL, Schepart BS (1993) Serum minor markers in non-small cell lung cancer. Cancer 73:605-609
12. Molina R, Agusti C, Mane JM, Filella X, Jo J, Joseph J, Gimenez N, Estape J, Ballesta AM (1994) CYFRA 21-1 in lung cancer: comparison with CEA, CA 125, SCC and NSE serum levels. Int J Biol Markers 9:96-101
13. Muraki M, Tohda Y, Iwanaga T, Uejima H, Nagasaka Y, Nakayima S (1996) Assessment of serum CYFRA 21-1 in lung cancer. Cancer 77:1274-1277
14. Nishimura H, Kambe M, Futagami K, Morishita K, Tsubokura T (1991) Fuzzy realization in clinical test database system. Int J Biomed Comput 28:289-296
15. Paone G, De Angelis G, Portalone L, Greco S, Giosué S, Taglienti A, Bisetti A, Ameglio F (1997) Validation of an algorithm able to differentiate small-cell lung cancer (SCLC) from non-small-cell lung cancer (NSCLC) patients by means of a tumour marker panel: analysis of the errors. Br J Cancer 75:448-450
16. Pathak A, Pal SK (1986) Fuzzy grammars in syntactic recognition of skeletal maturity from X-rays. IEEE Trans Systems Man Cybern 16:657-667
17. Plebani M, Basso C, Navaglia F, De Paoli M, Tommasini A, Cipiriani A (1995) Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results? Br J Cancer 72:170-173
18. Rau G, Becker K, Kaufmann R, Zimmermann HJ (1995) Fuzzy logic and control: principal approach and potential applications in medicine. Artif Organs 19:105-112
19. Sanchez E (1977) Solutions in composite fuzzy relation equations. Application to medical diagnosis in Brouwerian logic. In: Gupta MM, Saridis GN, Gaines BR (eds) Fuzzy automata and decision processes. North Holland, New York, pp 221-234
20. Sanchez E (1998) Fuzzy-logic and inflammatory protein variations. Clin Chim Acta 270:31-42
21. Spinazzi A, Soresi E, Boffi R, Nonis A, Noseda A, Cobelli S, Scanni A (1994) Evaluation of neuron-specific enolase, tissue polypeptide antigen as markers for staging and monitoring response to therapy of lung cancer. Cancer Detect Prev 18:209-220
22. Stieber P, Dienemann H, Hasholzner U. Müller C, Poley S, Hofmann K, Fatch-Moghadam A (1993) Comparison of cytokeratin fragment 19 (CYFRA21-1), tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) as tumour markers in lung cancer. Eur J Clin Chem Clin Biochem 31:689-694
23. Stieber P, Dienemann H, Schmitt UM, Reinmiedl J, Hasholzner U, Reiter W, Hofmann K, Schalhorn A, Yamaguchi K (1997) Pro-Gastrin-Releasing Peptide (ProGRP) - a new marker in small-cell lung carcinomas. J Lab Med 21:336-334
24. Yang HB, Hsu P-I, Lee JC, Chan CH, Lin XZ, Chow NH (1995) Adenoma-carcinoma sequence: a reappraisal with immunohistochemical expression of ferritin. J Surg Oncol 60:35-40
25. Zadeh LA (1965) Fuzzy sets. Information and Control 8:338-353
26. Zimmermann HJ (1991) Fuzzy set theory and its application, 2nd edn. Kluwer, Boston